Surgical Oncologists and the COVID-19 Pandemic: Guiding Cancer Patients Effectively through Turbulence and Change

被引:30
作者
Hwang, E. Shelley [1 ,2 ]
Balch, Charles M. [3 ]
Balch, Glen C. [4 ]
Feldman, Sheldon M. [5 ]
Golshan, Mehra [6 ]
Grobmyer, Stephen R. [7 ,8 ]
Libutti, Steven K. [9 ]
Margenthaler, Julie A. [10 ]
Sasidhar, Madhu [7 ,8 ]
Turaga, Kiran K. [11 ]
Wong, Sandra L. [12 ]
McMasters, Kelly M. [13 ]
Tanabe, Kenneth K. [14 ]
机构
[1] Duke Univ, Dept Surg, Durham, NC USA
[2] Duke Canc Inst, Durham, NC USA
[3] Univ Texas MD Anderson Canc Ctr, Div Surg Oncol, Houston, TX 77030 USA
[4] Emory Univ, Dept Surg, Atlanta, GA USA
[5] Montefiore Einstein Ctr Canc Care, Dept Surg, Bronx, NY USA
[6] Brigham & Womens Hosp, Dept Surg, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA
[7] Cleveland Clin Abu Dhabi, Oncol Inst, Abu Dhabi, U Arab Emirates
[8] Cleveland Clin Abu Dhabi, Pulm & Crit Care Med Inst, Abu Dhabi, U Arab Emirates
[9] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
[10] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA
[11] Univ Chicago, Pritzker Sch Med, Dept Surg, Chicago, IL 60637 USA
[12] Geisel Sch Med, Dept Surg, Hanover, NH USA
[13] Univ Louisville, Sch Med, Dept Surg, Louisville, KY 40292 USA
[14] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA
关键词
D O I
10.1245/s10434-020-08673-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The COVID-19 pandemic has posed extraordinary demands from patients, providers, and health care systems. Despite this, surgical oncologists must maintain focus on providing high-quality, empathetic care for the almost 2 million patients nationally who will be diagnosed with operable cancer this year. The focus of hospitals is transitioning from initial COVID-19 preparedness activities to a more sustained approach to cancer care. Methods Editorial Board members provided observations of the implications of the pandemic on providing care to surgical oncology patients. Results Strategies are presented that have allowed institutions to successfully prepare for cancer care during COVID-19, as well as other strategies that will help hospitals and surgical oncologists manage anticipated challenges in the near term. Perspectives are provided on: (1) maintaining a safe environment for surgical oncology care; (2) redirecting the multidisciplinary model to guide surgical decisions; (3) harnessing telemedicine to accommodate requisite physical distancing; (4) understanding interactions between SARS CoV-2 and cancer therapy; (5) considering the ethical impact of professional guidelines for surgery prioritization; and (6) advocating for our patients who require oncologic surgery in the midst of the COVID-19 pandemic. Conclusions Until an effective vaccine becomes available for widespread use, it is imperative that surgical oncologists remain focused on providing optimal care for our cancer patients while managing the demands that the COVID-19 pandemic will continue to impose on all of us.
引用
收藏
页码:2600 / 2613
页数:14
相关论文
共 42 条
[1]  
AKLADIOS C, 2020, J GYNECOL OBSTET HUM, V49
[2]  
*AM AC OT HEAD NEC, 2020, AAO HNS PO STAT OT C
[3]  
*AM SOC AN, COVID 19 FAQS 2020
[4]  
American College of Surgeons, Standard Operating Procedure (SOP) for Triage of Suspected COVID-. 19 Patients| COVID-19| CDC Internet
[5]  
[Anonymous], COVID 19 EL CAS TRIA
[6]  
Antonoff M, 2020, ANN THORAC SURG, V110, P692, DOI [10.1016/j.athoracsur.2020.03.005, 10.1016/j.jtcvs.2020.03.061]
[7]  
Asiri Abdulmajid, 2018, Acta Inform Med, V26, P201, DOI 10.5455/aim.2018.26.201-206
[8]   Management of Cancer Surgery Cases During the COVID-19 Pandemic: Considerations [J].
Bartlett, David L. ;
Howe, James R. ;
Chang, George ;
Crago, Aimee ;
Hogg, Melissa ;
Karakousis, Giorgos ;
Levine, Edward ;
Maker, Ajay ;
Mamounas, Eleftherios ;
McGuire, Kandace ;
Merchant, Nipun ;
Shibata, David ;
Sohn, Vance ;
Solorzano, Carmen ;
Turaga, Kiran ;
White, Richard ;
Yang, Anthony ;
Yoon, Sam .
ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (06) :1717-1720
[9]  
BERLINGER N, 2020, ETHICAL FRAMEWORK HL, P1
[10]   Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors [J].
Bersanelli, Melissa .
IMMUNOTHERAPY, 2020, 12 (05) :269-273